West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) has received a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the company, MarketBeat reports.

Fintel reports that on January 8, 2025, Citigroup initiated coverage of West Pharmaceutical Services (NYSE:WST) with a Buy ...

The upcoming season is the Philadelphia theatre's 217th. Walnut Street Theatre (WST) has revealed the lineup of productions ...

OlyBet has been announced as an official partner of French Rugby club Stade Toulousain. Stade Toulousain are the current Top ...

Citi has initiated coverage of West Pharmaceutical Services (WST), a provider of pharmaceutical packaging and injectable ...

Citi initiated coverage of West Pharmaceutical (WST) with a Buy rating and $400 price target West is a provider of packaging and injectable ...

OlyBet is thrilled to announce an agreement with Stade Toulousain, the powerhouse French Rugby club and the current Top 14 ...

West Pharmaceutical Services (WST) has received a new Buy rating, initiated by Citi analyst, Patrick B Donnelly.Stay Ahead of the ...

Check the time stamp on this data. Updated AI-Generated Signals for West Pharmaceutical Services Inc. (WST) available here: ...

West Pharmaceutical Services (WST) stock is down 16% due to deteriorating fundamentals, with emphasis on future growth ...

This was the stock's second consecutive day of losses.

Cliff Thorburn collected a cheque for £37,500 when he won the Masters title for a second time with a 9-6 win over Doug Mountjoy in 1985 at Wembley.